TechGuru , - after I listened to Gilead conference
Post# of 148293
In HIV they talking mostly how the future is PrEP , and I agree with that , and they happy how Truvada did and next Descovy will do as well and better...
Those drug will be lost when Leronlimab will be approved , and if in one and a half to two years Leronlimab might be once a month injection, it will be perfect for PrEP.
First time I realized today that Gilead is in big problem ,
I am interested with whom we signed non-binding contract for HIV ...
All IMO.